[ Inglês] CML Patient Story: A 20-Year Survivor Shares His Clinical Trial Experience

Published on

Topics include: Patient Stories

Meet chronic myelogenous leukemia (CML) patient advocate Mel Mann, the longest living #Gleevec survivor, as he describes his clinical trial experience and explains how participating led to a major molecular response with over a 20-year survival. Cecelia Mann, Mel’s wife and care partner, also shares how she supported Mel’s decision to join a clinical trial, and how others can find clinical trial support through The Leukemia & Lymphoma Society (LLS). Tune in to hear their story

This is a Patient Empowerment Network program produced by Patient Power. We thank AbbVie, Inc., Astellas, Celgene Corporation, and Novartis for their support.

View more programs featuring , and

Produced in association with

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Andrew Schorr:

And then you're left with a number of possible clinical trials that you have, and you can take that back to the doctor and you can discuss that with him.  So that's one of the things I talk with them about.  

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Related Programs

Ed’s Story: The Impact of Modern Medicine and Clinical Trials on My Lung Cancer

Meet Ed Cutler, a lung cancer survivor and advocate from Tampa, Fla., as he shares the ups and downs of his treatment journey; from standard care to two clinical trials, to help others understand the positive impact innovative therapies can have.

Published:

Clinical Trial MythBusters: What Is the Value of Diversity in Clinical Trials?

Is diversity, gender, age and ethnicity important in clinical trials? Mel Mann, a 20+ year CML survivor and a a highly respected leader in the field of clinical oncology weigh in.

Published:

Step One in Trial Participation: How Can Patients Learn About New Trials?

Myeloma survivor Reina Weiner and Lazarex chairman Dana Dornsife discuss ways patients can learn about new clinical trial opportunities and share resources to help alleviate the financial burden.

Published:

Transparency in Clinical Trials: Data, Safety and Monitoring of Cancer Patients

Many patients wonder; how safe are clinical trials? How transparent is the data from clinical research? Tune in to hear Dr. Mike Thompson and Jim Omel discuss clinical trial care and how the efficacy of new cancer treatments is determined.

Published:

Precision Medicine: Can Biomarkers Help Patients Find a Good Fit for Clinical Trials?

A panel of experts discuss how precision medicine may influence trial eligibility, cost of treatment, pace of drug development and more. Can biomarkers make the clinical trial process more efficient? Watch now to find out.

Published:

Evaluating Inclusion and Exclusion Criteria in Clinical Trials

Eligibility criteria determines who can and cannot participate in a clinical trial. Do today’s studies reflect the actual patient population? Why is inclusion so narrow in some cases? Watch now to hear from Dr. Mike Thompson and Jim Omel.

Published:

Are Clinical Trials Available to the Older Patient Population?

Is there a cut-off age to clinical trial participation? Watch now to hear CLL expert Dr. Nicole Lamanna discuss the importance of elderly representation and eligibility to drive research forward.

Published:

Randomization in Clinical Trials: An Expert Explains Patient Equality

Patient advocate Jim Omel tackles the hot-button issue of randomization in clinical trials. What determines patient equality? How are treatments allocated amongst patients? Watch now to learn more.

Published:

How Can Clinical Trials Be Improved to Enhance the Patient Experience?

Patient advocate Jim Omel and leading expert Dr. Mike Thompson break down the design and purpose of clinical trials and give their perspective on how it could be more patient-friendly.

Published:

How Do Clinical Trials Contribute to Research?

How do clinical trials challenge the standard of care, and when should patients consider joining? Watch now to learn more about trials from expert Dr. Tomasz Beer.

Published:

How Do I Navigate Clinical Trials That Are Right for Me?

The search for the right clinical trial can be overwhelming. Tune in to hear from Tricia Holtz as she shares a valuable resource for patients to help guide the decision-making process and to find a trial that’s right for them.

Published:

Clinical Trial MythBusters: How Have Clinical Trials Evolved?

The design of clinical trials had to adapt to better meet the needs of both patients and health experts. Find out from Dr. Heather Wakelee how the field has changed.

Published:

Advertisement
Junte-se a nossa comunidade Cadastre-se para Eventos Leia nosso último blog
Advertisement

Page last updated on February 14, 2019